Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMoleculin Biotech, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $5.52 at 09:24 AM on Oct 20, then ran to $6.40 +16% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is MBRX up today? It is at $6.58 (+11.77%), and our scanner flagged it 21 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MBRX spikes, and full due diligence on MBRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MBRX 21 times in the last 30 days. Create a free account to track $MBRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MBRX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystMoleculin Announces Reverse Stock SplitReverse split 1-for-2Status pending stockholder approval, from the latest SEC filing. Read it →Across every filing on file, supply equal to at least 288.1% of the tradeable float is in play - 288.1% more can still be issued.
Some filings did not state a size, so these are floors.
Shelf sizes are dollars, so shares are estimated at today's price.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
At-the-market (ATM) program — sells new shares into the market gradually over time
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on MBRX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
MBRX last traded at $6.58, up 11.77% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Moleculin Biotech, Inc. (MBRX) is next expected to report earnings on Thursday, November 12, 2026, about 18 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The MBRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MBRX 21 times in the last 30 days.
MBRX (Moleculin Biotech, Inc.) trades on XNAS, with a market cap of about $7M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MBRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MBRX discussion
Sign in to ask a question or join the discussion.